Megan McMahon

Pfizer
Executive Director, Regulatory CMC
Megan McMahon is a Executive Director and group leader in Global Regulatory CMC at Pfizer based in Groton, Connecticut. She sponsors Pfizer’s Stability Council and is a member of Pfizer’s Impurity Council. Megan co-leads the IQ Science and Risk Based Stability Working Group, which advocates for a holistic approach to stability development and retest period/shelf life assignments, leveraging multiple stability tools and a stability risk assessment process. Megan is currently Rapporteur for the revision of the ICH Stability Guidelines (ICH Q1 and Q5C).